Nanotechnology for the treatment of breast cancer was developed by scientists of the University of Cyprus
Scientists of the University of Cyprus, taking advantage of the new perspectives offered by nanotechnology in pharmaceutical technology, have prepared polymeric nanoparticles for the planned transfer of the antihistamine substance Tranilast to the cancerous breast tumor, according to a relevant press release from the University of Cyprus.
